Introduction
The remaining four cleavages (at the NS3/NS4A, NS4A/ NS4B, NS4B/NS5A, and NS5A/NS5B sites) are mediated Infection by hepatitis C viruses (HCVs) is a compelling by a separate serine protease that resides in the human medical problem. The virus was formally identi-N-terminal one-third of NS3 (Bartenschlager et al., 1993 ; fied by molecular cloning and sequencing around 1989 Eckart et al., 1993; Grakoui et al., 1993a Grakoui et al., , 1993b Grakoui et al., , 1993c Choo et al., 1989; . Hijikata et al., 1993a Hijikata et al., , 1993b Tomei et al., 1993 ; Manabe HCV has now emerged as the causative agent for most et al., 1994) . Questions remain concerning the functions cases of non-A, non-B hepatitis, with an estimated huof NS4B and NS5A, but the roles of the other nonstructuman seroprevalence of 1% globally (Purcell, 1994 ; Van ral proteins are becoming clearer. NS5B appears to be der Poel, 1994) . Four million individuals may be infected the viral RNA polymerase (Takamizawa et al., 1991 ; Behin the United States alone (Alter and Mast, 1994) . Upon rens et al., 1996) and the C-terminal two-thirds of NS3 first exposure to HCV, approximately 20% of infected an NTP-dependent helicase (Miller and Purcell, 1990 ; individuals develop acute clinical hepatitis while others Suzich et al., 1993; Jin and Peterson, 1995; Kanai et al., appear to resolve the infection spontaneously. However, 1995; Kim et al., 1995) . NS4A is a 54-residue amphipathic in most instances the virus establishes a chronic infecpeptide, with a hydrophobic N-terminus and a hydrotion that persists for decades (Iwarson, 1994) . This usuphilic C-terminus (Failla et al., 1994 ). It appears to serve ally results in recurrent and progressively worsening multiple functions: acting as a cofactor for the NS3 proliver inflammation, often leading to more severe disease tease and possibly assisting in the membrane-localizastates such as cirrhosis and hepatocellular carcinoma tion of NS3 and other viral replicase components (Lin (Saito et al., 1990; Kew, 1994) . The prospects for effecet al., 1995; Tanji et al., 1995a; Shimizu et al., 1996) . tive anti-HCV vaccines remain uncertain and the only Great efforts have been made to characterize the established therapy for HCV disease is interferon treatmechanisms by which the NS3 serine protease domain ment. However, interferons have significant side effects processes the downstream gene products. To summa- (Renault and Hoofnagle, 1989; Janssen et al., 1994) and rize, the NS3/NS4A cleavage appears to occur in cis, induce long term remission in only a fraction ‫)%52ف(‬ whereas the NS4A/NS4B, NS4B/NS5A and NS5A/NS5B of cases (Weiland, 1994) . For these reasons, there is processing events probably occur in trans. NS4A seems considerable interest in developing more effective anticritical to this scheme of events, enhancing the proteo-HCV therapies.
Early analyses of the HCV single-positive strand RNA lytic efficiency at all of the sites. Many deletion mapping refined model consists of residues 2-180 of NS3 (residues 1028-1206 of the HCV polyprotein) and residues 21-39 of NS4A (residues 1678-1696 of the polyprotein) in the first complex (complex A), NS3 residues 29-180 (1055-1206) and NS4A residues 21-36 in the second the refined model is shown in Figure 2 . Atomic temperature factors for the two complexes are closely matched (average B ϭ 29.2 Å 2 and 29.8 Å 2 , respectively), and and mutagenesis experiments have been performed reneither complex contains nonglycine main-chain torsion cently to probe the regions of NS3 and NS4A that interangle values located in unfavorable regions of a Ramaact. However, to date, there is no direct structural inforchandran plot. Apart from the disordered N-terminus in mation about either component.
complex B, the two tNS3:NS4A complexes in the asymHere we present the X-ray crystal structure, at 2.5 Å metric unit are very similar, with a root-mean-square resolution, of a recombinant truncated HCV NS3 protedeviation (rmsd) of 0.6 Å for 159 equivalent C␣ positions ase domain (tNS3) complexed with a synthetic peptide (polyprotein residues 1057-1205 from NS3 and residues that encompasses the essential NS3-binding region of 22-31 of NS4A). The similarity is even greater within the NS4A (Lin et al., 1995) . We believe that the information core of the complex, increasing our confidence that this provided by this structure will have far-reaching consestructure is representative of the protease domain of quences for the global effort to develop more effective the full-length NS3 protein. HCV therapies.
Results and Discussion
Structure of tNS3
The three-dimensional structure of the tNS3:NS4A complex reveals that the HCV NS3 serine protease domain Structure Determination and Analysis The structure of the truncated NS3 protease doadopts a chymotrypsin-like fold. The complex consists of two structural domains, each containing a twisted ␤ main:NS4A peptide (tNS3:NS4A) complex was determined at 2.7 Å resolution by multiple isomorphous resheet incorporating a "Greek key" motif ( Figure 3 ). The C-terminal domain (residues 1120-1206) contains the placement and is presently refined at 2.5 Å resolution (Table 1) . The rhombohedral crystals used in this study conventional six-stranded ␤ barrel, common to nearly all members of the chymotrypsin family, followed by a (space group R32; a ϭ b ϭ 225.0 Å , c ϭ 75.5 Å ) contain two tNS3:NS4A complexes per asymmetric unit. The structurally conserved ␣ helix. The core of this barrel is R sym ϭ ⌺ԽI Ϫ ͗I͘Խ/⌺I, where I ϭ observed intensity, ͗I͘ ϭ average intensity obtained from multiple observations of symmetry related reflections. R iso ϭ ⌺ԽԽFPH-ԽFPԽԽ/⌺ԽFPԽ, where ԽFPԽ ϭ protein structure factor amplitude, ԽFPHԽ ϭ heavy-atom derivative structure factor amplitude. Phasing power ϭ rms (ԽF HԽ/E), where ԽFHԽ ϭ heavy-atom structure factor amplitude and E ϭ residual lack of closure. a Free R value was calculated using 9% of the data. packed with hydrophobic residues that emanate from 100 residues at its N-terminus, so it is unclear whether this protein has any structural equivalents to NS4A, ␤ all six strands of the ␤ barrel. The N-terminal domain (residues 1027-1119) contains eight ␤ strands rather strand A 0 , or helix ␣ 0 of tNS3:NS4A ( Figure 5 ). than six, including one strand contributed by NS4A. This array of ␤ strands gives rise to a ␤ sheet that superim-
Interactions with NS4A
The NS4A peptide forms a ␤ strand that lies between poses with most of the distorted barrel found in the N-terminus of chymotrypsin. Active site residues Hisstrands A 0 and A 1 of tNS3 ( Figure 3B ). All but two of the main-chain carbonyl and amide groups of residues Val-1083 and Asp-1107 reside in the N-terminal domain of the tNS3 protease, whereas Ser-1165 is located in the 23 to Leu-31 of NS4A form hydrogen bonds with either the N-terminal region of tNS3 or strand A1. This includes C-terminal domain. All three residues are situated in a cleft separating the two domains. Additionally, the hydrogen bonds to the side chains of Arg-1037 and Glu-1058. Several side chains from NS4A are buried in C-terminal domain contains a tetrahedrally coordinated metal ion, modeled here as a zinc, located at one end hydrophobic pockets formed by tNS3 and contribute to the hydrophobic core of the N-terminal domain (Figure of the ␤ barrel. This zinc ion appears to play a structural role in the enzyme by stabilizing the loops preceeding 6A). A total of 2400 Å 2 of surface area is buried by the interaction of NS4A with tNS3. Thus, NS4A should be ␤ strands A 2 and E 2 .
Structural comparisons between tNS3:NS4A and considered an integral structural component of the complex and probably plays a significant role in stabilizing other serine proteases currently in the Protein Data Bank (PDB) indicate that it shares the greatest similarity with tNS3. A wealth of biochemical and mutational data exists the Sindbis virus core protein (SCP) (Tong et al., 1993) , with an rmsd of 1.6 Å for 75 C␣ residues that comprise characterizing the interaction of NS4A with the NS3 protease domain. Multiple experiments have demonstrated the core and active site of each enzyme ( Figure 4B ). The structural agreement is better in the C-terminal domain, that a central hydrophobic region of NS4A, encompassing residues Gly-21 to Lys-34, is sufficient for NS3 where the six ␤ strands from each enzyme superimpose reasonably well. Similarly, the six ␤ strands in the binding and protease activation. Indeed, a synthetic peptide corresponding to this region substitutes for C-terminal domain of chymotrypsin closely match those in tNS3 ( Figure 4C ). On the other hand, only ␤ strands longer NS4A sequences in NS3 protease activation (Lin et al., 1995) . The structure of the tNS3:NS4A complex A1, B1, C1, and F1 in the N-terminal domain of tNS3:NS4A superimpose with the equivalent strands in either SCP provides an explanation for these results. All of the contacts observed in the complex occur in the region spanor chymotrypsin. The ␤ strand formed by the NS4A peptide is in the vicinity of strand D 1 of chymotrypsin in their ning residues 21 to 32 of NS4A. Interestingly, the requirement for only the central region of NS4A for full protease structural alignment, but this strand does not hydrogenbond to strand E 1 as is found in the ␤ barrel of chymoactivation has been demonstrated for the full-length NS3 enzyme as well as the isolated protease domain (Shimizu trypsin. The reported structure of SCP is missing over The location of the NS4A peptide within the fold of the enzyme is readily apparent. This figure was generated using Ribbons (Carson, 1991 (Carson, ). et al., 1996 , suggesting that the same interactions obare found in both. Despite this difference, the structure of NS4A is nearly identical in complex A and B. Mutaserved here occur in the full-length NS3:NS4A complex.
The interactions of NS4A with tNS3 can be divided tional analyses within the central region of NS4A have identified several residues that are critical for complex into two components: those with the N-terminal 30 residues of tNS3 and those with the core of tNS3. The former formation with NS3 and protease activation (Bartenschlager et al., 1995; Lin et al., 1995; Shimizu et al., are found in only one of the two tNS3:NS4A complexes in the asymmetric unit, whereas the latter interactions 1996). A strong correlation exists between the amount The structure of HCV tNS3 monomer A (yellow) was superposed on monomer B in (A), Sindbis virus capsid protease (PDB entry 2SNV) in (B), and chymotrypsin (PDB entry 5CHA) in (C). The orientation of the molecules is similar to that in Figure 2A . The side chains of the catalytic triads are also shown. Residues in bold have a C␣ rmsd of less than 2 Å in the overlay of all three structures. The catalytic triad residues are denoted by asterisks. Ligands to the zinc ion in HCV are underlined. The secondary structure elements are marked above the alignment and are labeled consistent with chymotrypsin notation. NS4A is located in the approximate location of strand D1 in chymotrypsin.
of buried surface area of a given NS4A residue in the NS4A promotes the membrane association of NS3 and stabilizes it from degradation by cellular proteases (Hijicomplex and the severity of the effect of mutating that residue on NS3 protease activation and complex stabilkata et al., 1993b) . In addition, NS4A has been found to stimulate the phosphorylation of NS5A, which is also ity ( Figure 6B ). Those NS4A residues that are buried in the core of tNS3, are believed to be membrane-associated (Tanji et al., 1995b) . Hydrophobicity analysis of the 54 amino acid most sensitive to mutation. The only exception is Gly-27, whose mutation to serine has a severe effect (Shimizu et NS4A protein suggests that the N-terminus may associate with membranes (Failla et al., 1994; despite its small buried surface area. Analysis of the structure indicates that this absolutely conserved et al. Tanji et al., 1995a) . More detailed analyses using multiple sequence alignments (Rost et al., 1995) glycine is situated such that mutations would result in steric clashes with the backbone of NS3 residue 1035.
support the hydrophobicity plots and predict that the N-terminal 20 residues of NS4A form a transmembrane helix. The NS3 protease activation region immediately The Role of NS4A The activation of the NS3 protease by NS4A may be a follows this, suggesting that NS4A holds the NS3 protease domain very close to the membrane and may serve result of NS4A incorporation into the N-terminal domain ␤ sheet, which is extended by up to two strands in the as a molecular tether that anchors the HCV replication machinery complex together at the cellular membrane. complex. This could lead to alterations in the active site by providing a more rigid and precise framework for residues that form the "prime-side" substrate-binding tNS3 N-Terminal Region As shown in Figure 4A , the two molecules of tNS3 in channel. In addition, activation via direct interactions of NS4A with the prime-side residues of the substrate are the asymmetric unit are very similar, with a C␣ rmsd of 0.6 Å for residues 1057-1206 and a side-chain rmsd of possible, although these would occur more than 10 Å away from the cleavage site. This is in contrast to the 1.4 Å over this same range. They differ mainly at the N-terminus with one molecule having well-defined strucmechanism of activation in chymotrypsin, where proteolytic processing of the polypeptide chain leads to the ture extending to residue 1028 and the other only to residue 1055. In spite of this difference, both complexes creation of a new N-terminus that interacts with "nonprime-side" of the substrate-binding channel. This recontain NS4A in essentially the same position, with a C␣ rmsd of 0.8 Å for residues 21-31. NS4A becomes sults in the formation of a cavity that can accommodate the P1 residue of the substrate (see Appel, 1986, for part of the N-terminal domain ␤ sheet and is located in approximately the same location as strand D 1 in SCP review). The tNS3 protease has an inherently open conformation in the analogous region. Other serine proteand chymotrypsin. In complex A, the N-terminus of NS3 forms a ␤ strand (A 0 ), an ␣ helix (␣ 0 ), and an extended ases such as ␣ lytic protease and subtilisin require a propeptide, which can function in trans, to obtain full chain leading into strand A1. This region is stabilized by main-chain hydrogen bonds between residues 1030-activity (Li et al., 1995) . These propeptides are believed to act as molecular chaperones by acting as competitive 1034 and NS4A, along with hydrophobic interactions between ␣0 and Val-24 and Val-26 of NS4A. Additionally, active site inhibitors around which the enzyme folds.
Experiments both in vivo and in vitro indicate that a salt bridge between residues flanking ␣0 (Arg-1037 and Asp-1051) helps stabilize the fold of this region and (Ding et al., 1996) . The pVIc peptide binds at the surface of the AVP, quite distant from the active site, and forms direct the polypeptide chain toward strand A1.
NS4A binding significantly inhibits cellular degradathe sixth strand of a ␤ sheet that comprises the core of the enzyme. It has been proposed that the activation of tion of NS3 (Hijikata et al., 1993b; Tanji et al., 1995a) , and this may result from NS4A ordering the NS3 N-terminal AVP by pVIc is due to alterations in the conformation of the active site, propagated by interactions of the region. The interaction of NS4A peptide with the core of NS3 buries 1650 Å 2 of surface area while the interacpeptide with noncontiguous segments of the protease, analogous to what we have proposed for tNS3 activation tion with the N-terminal region buries an additional 745 Å 2 . The removal of NS4A would cause disruption of the by NS4A. Sequence analysis and mutagenesis experiments in-N-terminal domain ␤ sheet and would likely result in either disordering of the N-terminal region or repacking dicate that a chymotrypsin-like serine protease resides within the NS3 N-terminal regions of other flaviviruses of this region against the core of tNS3, as they currently share only 250 Å 2 of buried surface area. The stabiliza- (Bazan and Fletterick, 1989) . Homology modeling of these proteases suggests that they have similar overall tion of the N-terminus of tNS3 by a cofactor may be similar to the stabilization of the N-terminus of trypsin folds to that of the HCV NS3 protease (P. R. C., unpublished data). However, flaviviruses require NS2B rather by calcium, which binds to a loop between strands D1 and E 1 (Gomez et al., 1977) .
than NS4A for protease activation (Chambers et al., 1993; Falgout et al., 1993) , and there is no sequence Deletions of the N-terminus of NS3 have shown that this region is important for complex formation with similarity between the HCV NS4A activation region and NS2B. Therefore, elucidation of the activation mecha-NS4A. NS3 constructs beginning at the true N-terminus (Ala-1027) can be activated and coimmunoprecipitated nisms of these viral proteases will require further biochemical or structural characterization. with NS4A as shown by in vitro translation and cell culture experiments. NS3 N-terminal truncations of 7-15 residues (constructs beginning between amino acids Zinc-Binding Site 1034 and 1042) result in products that can still be actiThe HCV NS3 protease structure has a metal ion tetrahevated by NS4A but appear less competent in complex drally coordinated by Cys-1123, Cys-1125, Cys-1171, formation as judged by immunoprecipitation experiand through a water molecule to His-1175 (Figures 3 ments (Bartenschlager et al., 1995; Failla et al., 1995;  and 7). This metal was originally modeled as zinc, based Koch et al., 1996) . These N-terminal residues of NS3 on comparisons of its surrounding architecture with encompass ␤ strand A 0 , which packs onto NS4A, and zinc-binding motifs found in the PDB. Preliminary results removing these residues reduces the total amount of obtained via atomic absorption spectroscopy confirm tNS3 surface area contact with NS4A by approximately the presence of zinc in samples of tNS3:NS4A (details one-third. NS3 constructs that begin at residue 1048 or will be published elsewhere; T. F., M. D. D., K. A. M., 1049 are appreciably less stable, and in most cases J. A. T., unpublished data). The existence of this binding cannot be activated by NS4A (Satoh et al., 1995; site was previously predicted from sequence analysis et al., 1995a; Koch et al., 1996) . In these proteins strand and model building (P. R. C., unpublished data). The A 0 and helix ␣ 0 are missing. Of note is the deletion of ligands to the zinc are conserved among the known HCV Ser-1046, which is buried against NS4A in the complex and hepatitis G virus (HGV) NS3 sequences, but there and has been shown by mutagenesis to be critical for is no discernible evidence for metal-binding motifs in the NS4A activation (Koch et al., 1996) . Replacement of this analogous regions of other flavivirus proteases (P. R. C., residue by a hydrophobic residue, such as valine, results unpublished data). Individual mutations of any of the in a protease that can still be activated by NS4A, HCV NS3 metal-coordinating cysteine residues to alawhereas replacement with a glutamic acid residue eliminine greatly reduces protease activity, whereas mutanates the NS4A activation. This is in good agreement tion of the histidine has much less effect (Hijikata et al., with the structure. Proteases truncated at residue 1049 1993a; S. P. C. et al., unpublished data). This is consisare also inherently unstable. This is likely due to the lack tent with the indirect interaction of His-1175 with the of significant interactions of residues 1049-1055 with zinc ion. An essential zinc has previously been described either tNS3 or NS4A peptide. Truncations to residue for rhinovirus 2A protease (Sommergruber et al., 1994) . 1055 retain some residual activity, but are not activated This protein is believed to also have a chymotrypsinby NS4A .
like fold, although the nucleophilic residue is a cysteine rather than a serine. Sequence alignments of rhinovirus 2A protease and the corresponding regions in other Peptide Activation of Other Proteases The activation of the HCV NS3 protease by a short peppicornaviruses suggests that a zinc could be coordinated by three cysteines and a histidine in approximately tide fragment of NS4A is reminiscent of the activation mechanism of the human adenovirus-2 L3 23K protease the same locations as those seen in HCV NS3 protease. Mutations of the corresponding zinc ligands proposed (AVP) by an 11 amino acid cofactor encoded by the C-terminus of the pVI protein (pVIc) (Webster et al., in poliovirus 2A protease also reduce activity (Yu and Lloyd, 1992) . 1993). In AVP, the peptide binds to form a 1:1 complex and increases k cat by 350-fold (Mangel et al., 1996) . The
No clear evidence has been found for zinc-activation of the HCV NS3 protease activity in vitro, and EDTA structure of the AVP-pVIc complex demonstrated that this 204 residue cysteine protease has a unique fold appears to be a very weak inhibitor of NS3 protease activity (Lin and Rice, 1995) , suggesting that the ion is that is grossly similar to those of papain and subtilisin The Zn 2ϩ coordination displays near perfect tetrahedral geometry. Coordination to the sulphur and oxygen ligands is depicted with narrow lines. Zn 2ϩ -sulphur distances to Cys-1123, Cys-1125, and Cys-1171 are 2.29 Å , 2.34 Å , and 2.29 Å , respectively, and the Zn 2ϩ -OH2 distance is 2.37 Å . Atoms are color coded by element type: carbon in gray, nitrogen in blue, oxygen in red, sulphur in yellow, and zinc in cyan. This figure was generated using Ribbons (Carson, 1991) . tightly bound and may require partial denaturation of catalytic triad is highly conserved, as are the positions of the backbone amides of Gly-1163 and Ser-1165, which the protein for its removal. Similar observations have also been reported for the rhinovirus 2A protease (Somform the oxyanion hole. Further, the twisted strand encompassing residues 1181-1184 superimposes well mergruber et al., 1994). Because it is located more than 20 Å away from the catalytic Ser-1165, the bound zinc with the corresponding residues in chymotrypsin (residues 214-217) and other enzymes of this family. This ion is presumed to perform a structural rather than a catalytic role. One possible role of the zinc ion may be strand has been shown to make hydrogen bonds with the P3 carbonyl and the P1 and P3 amides of peptidomito induce stability at the active site through ␤ strand D 2 , which separates the active site Ser-1165 and one of the metic serine protease inhibitors such as aldehydes and trifluoromethylketones (Edwards and Bernstein, 1994) . zinc ligands, Cys-1171. The zinc-binding site is also located near the interface of the two domains in the From the standpoint of inhibitor design, however, there are several important differences between the HCV NS3 protease and may have an effect on the relative conformations of these domains, which both contribute resiserine protease and other members of the chymotrypsin family. Comparisons with chymotrypsin and elastase dues forming the active site and substrate-binding groove.
indicate that the loop between strand E 1 and the catalytic Asp-1107, which forms part of the peptide substratebinding channel, is shorter by six residues in NS3 proteThe NS3 Active Site The catalytic machinery of the HCV NS3 serine protease ase. Wherever a shortened loop has been observed in this region in other cellular serine proteases, such as ␣ appears to be quite similar to that of other serine proteases with chymotrypsin-like folds. The location of the lytic protease, it appears to be compensated for by an altered conformation of the loop between strands B2 and Conclusions We have described the first atomic-resolution crystal C2 such that a well-defined substrate-binding channel is structure of the HCV NS3 serine protease domain, commaintained (Fujinaga et al., 1985) . In HCV tNS3, however, plexed with an NS4A activation peptide. The structure the B 2 -C 2 loop is 14-15 residues shorter than in chymoreveals a number of important features. First, the entrypsin and ␣ lytic protease, resulting in a relatively solzyme has a chymotrypsin-like fold with structural simivent-exposed substrate-binding channel. Finally, in larity to the protease encoded by the Sindbis capsid trypsin and thrombin there is a third loop spanning resiprotein. Second, the activation region of NS4A forms a dues 60A-60G that is completely absent in HCV tNS3.
␤ strand that intercalates into the N-terminal domain ␤ Together, these loops have been shown to make crucial sheet in the core of the enzyme. The extensiveness of interactions with the P2, P3, and P4 moieties of inhibitors the interactions between NS3 and NS4A suggests it of all other members of this enzyme family including should be considered as an alternative site for the deelastase, thrombin, trypsin, and factor Xa. The absence sign of anti-HCV drugs. Third, a zinc-binding motif is of these longer loops in HCV tNS3, and the contact observed, which appears to have a structural role, given points they provide, is likely to make the design of low its distance from the enzyme active site. Fourth, several molecular weight inhibitors quite challenging.
loops found in other chymotrypsin family proteases are missing from HCV. These loops normally play a critical role in defining the shapes of the non-prime-side sub-P1 Specificity Pocket strate-binding pockets. In the HCV tNS3 protease, the Cysteine is found at the P1 position in three of the four absence of these loops renders the substrate-binding known cleavage sites for HCV NS3 protease. The fourth groove relatively featureless, and this constitutes a chalknown P1 residue is threonine, which occurs at the NS3/ lenge for drug design efforts. It is therefore anticipated NS4A site. This site is unique in that cis cleavage apthat the generation of high-resolution structural informapears to be preferred (Bartenschlager et al, 1993 ; Tomei tion for enzyme-inhibitor complexes may be crucial for et al, 1993). Phe-1180 is located at the bottom of the the optimization of potent, drug-like NS3 protease inhibsubstrate P1 pocket (Figure 1) . It is clearly in position itors. Finally, the information derived from the HCV tNS3 to make favorable van der Waals interactions with the protease structure may help in further understanding P1 residue, and it is known that Cys-Phe interactions homologous viral proteases encoded by related pathoare favorable (Burley and Petsko, 1988) . Failla et al. genic flaviviruses such as the hepatitis G, dengue, and (1996) have demonstrated that the double mutant yellow fever viruses. Phe1180Thr and Ala1183Gly increased the size of the In vitro HCV replication systems, which would allow S1 pocket, enabling the cleavage of substrate with a unambiguous confirmation of this protease as an essenbulkier Phe residue at P1. tial enzyme in viral replication, are not yet available. Based on homology modeling studies, the residues However, it is known that mutations that inactivate hothat form the P1 specificity pockets of flavivirus NS3 mologous NS3 protease in yellow fever virus result in proteases are quite different to those of the HCV NS3 the loss of infectivity (Chambers et al., 1990) . Mutations that eliminate NS3-dependent cleavage sites in yellow protease (P. R. C., unpublished data). Specifically, a fever virus also result in noninfectious clones (Nestoroconserved aspartate is found six residues before the wicz et al. , 1994; Chambers et al., 1995) . This, combined catalytic serine and would be expected to be located with the observations that the polyproteins of all the at the bottom of the P1 pocket, exactly as in thrombin.
flaviviruses appear to be cleaved at approximately the This suggests a preference for arginine or lysine, consissame location by their respective NS3 proteases, sugtent with the observed in vivo cleavage specificities of gests proteolytic processing at multiple sites is imporflavivirus proteases (Chambers et al., 1989) .
tant for HCV replication. The structure we describe clarifies a multitude of observations derived from biochemical studies, modeling tNS3-NS4A Interaction Site: Alternate predictions, mutational analyses, and inhibitor studies; Design Target all suggesting that the NS3 protease had a simple chyAs discussed above, and as shown in Figure 6 , the motrypsin-like fold, yet displayed complex NS4A-contact surface between tNS3 and NS4A is quite extendependent activation behavior. The intimate interacsive and provides another possible site for the design tions between NS4A and NS3 clearly define NS4A as an of anti-HCV chemotherapeutic agents. Among 80 deintegral part of the active enzyme structure and help to posited NS4A sequences in GenBank, there are only explain its role in stabilizing NS3. This structure also two NS4A residues in the tNS3-binding region that are allows investigations in the hepatitis C field to be redi-100% conserved, Ile-25 and Gly-27. In addition, several rected toward more precise goals, focusing on the exact other NS4A residues that make significant contact with mechanism of activation by NS4A, the role of the structNS3 are always hydrophotural zinc ion, the spatial relationships between the NS3 bic. Finally, the principal tNS3 residues that make conprotease and helicase domains, and the mechanisms tact with the conserved residue Ile-25 of NS4A (Proby which NS3 might interact with other viral replicative 1114, Ile-1090 , Val-1055 , and Val-1062 are also highly components. It is anticipated that the availability of this conserved among 28 NS3 sequences in GenBank. These information will stimulate efforts to develop more effecdata suggest that it may be possible to design relatively tive anti-HCV therapies, whether they target the NS3 small, predominantly hydrophobic molecules to comprotease or not, and may also provide benefit to related medical problems. pete with NS4A binding and activation.
Experimental Procedures
The peptide was purified by preparative HPLC on a Waters Delta Pak C18, 15 m, 300 Å column (30 mm ϫ 300 mm) eluting with a linear gradient of acetonitrile (15%-40%) in 0.1% aqueous trifluoroExpression and Purification of tNS3 acetic acid over 35 min (flow rate of 22 ml/min). Peptide purity was The truncated NS3 serine protease domain (tNS3) was cloned from confirmed by analytical HPLC. The sequence was confirmed by a cDNA of the hepatitis C virus H strain (Grakoui et al., 1993b) .
direct N-terminal sequence analysis and matrix-assisted laser deThe first 181 amino acids of NS3 (residues 1027-1207 of the viral sorption mass spectrometry (Kratos MALDI I), which showed the polyprotein) have been shown to contain the serine protease domain correct (M ϩ H) ϩ and (M ϩ Na) ϩ molecular ions. of NS3 that trans-processes all four downstream sites of the HCV polyprotein (Lin et al., 1994b) , so we expressed a (His)6-fusion proCrystallization and Data Collection tein based on this tNS3. The plasmid pET-BS(ϩ)/HCV/T7-NS3181-Crystals of the tNS3/4A complex were grown by hanging-drop vapor His was derived from pTM3/HCV/1027-1207 (NS3181) (Lin et al., diffusion over a reservoir of 0.1 M MES, 1.8 M NaCl, 0.1 M sodium/ 1994b), by using polymerase chain reaction to introduce epitope potassium phosphate, 10 mM ␤-mercaptoethanol (pH 6.5). The crystags and new restriction sites. A T7-tag (ASMTGGQQMG), from the tals grew over the course of 2-3 weeks, to final dimensions of about N-terminus of the gene 10 protein of the T7 bacteriophage (Tsai et 0.1 ϫ 0.1 ϫ 0.25 mm. They belong to space group R32, with unit al., 1992), was placed at the N-terminus of the tNS3 domain. Two cell dimensions a ϭ b ϭ 225.0 Å , and c ϭ 75.5 Å , and contain two linker residues (GS) were placed at the tNS3 C-terminus, followed tNS3/4A complexes per asymmetric unit. by the (His)6-tag. E. coli JM109(DE3) cells, freshly transformed with Statistics for data collection, heavy atom refinement, and crystalthe pET-BS(ϩ)/HCV/T7-NS3181-His plasmid, were grown at 37ЊC in lographic refinement are given in Table 1 . All heavy atom soaks complex media supplement with 100 g/ml ampicillin, in a 10 L were done in hanging-drops over the same reservoir as used for fermentor (Braun). When the cell density reached an OD 600 of 3-4 crystallization. Crystals were transferred to a stabilizing solution (50 the temperature of the culture was rapidly reduced to 30ЊC, and mM MES, 2.0 M NaCl, 0.1 M sodium/potassium phosphate, 10 mM induction was immediately initiated by the addition of 1 mM IPTG.
␤-mercaptoethanol, and 20% glycerol [pH 6.2]) and then frozen in Cells were harvested at 2 hr postinduction and flash frozen at Ϫ70ЊC a dry nitrogen gas stream at 100 K (Molecular Structure Corp., prior to purification.
Houston, TX) for data collection. Data was acquired by oscillation The tNS3 was purified from the soluble fraction of the recombinant photography on a Rigaku R-AXIS IIC phosphor imaging area detec-E. coli lysates as follows, with all procedures being performed at tor mounted on a Rigaku RU200 rotating anode generator (MSC), 4ЊC unless stated otherwise. Cell paste (75-100 g) was resuspended operating at 50 kV and 100 mA. Measured intensities were intein 15 volumes of 50 mM HEPES, 0.3 M NaCl, 10% glycerol, 0.1% grated, scaled, and merged using the HKL software package (Z. ␤-octyl glucoside, 2 mM ␤-mercaptoethanol (pH 8.0). Cells were Otwinowski and W. Minor). ruptured using a microfluidizer and the homogenate was clarified by centrifugation at 100,000 ϫ g for 30 min. The supernatant was Phasing, Model Building, and Refinement brought to 50 mM HEPES, 20 mM imidazole, 0.3 M NaCl, 27.5%
Heavy atom positions were located by inspection and confirmed glycerol, 0.1% ␤-octyl-glucoside, 2 mM ␤-mercaptoethanol (pH 8.0) with difference Fourier syntheses. Heavy atom parameters were and applied at 1.0 ml/min to a 7.0 ml Ni-Agarose affinity column, refined and phases computed to 3.1 Å using the program PHASES equilibrated in the same buffer. After loading, the column was (Furey and Swaminathan, 1996) . MIR phases were improved and washed with 10-15 volumes of equilibration buffer and the bound extended to 2.7 Å by cycles of solvent flattening (Wang, 1985) comproteins were eluted with equilibration buffer containing 0.35 M bined with histogram matching (Zhang and Main, 1990) using the imidazole. The protein was then size-fractionated on two columns in CCP4 crystallographic package (Collaborative Computation Project, series (each 2.6 cm ϫ 90 cm) packed with Pharmacia high resolution 1994). The resulting electron density map displayed nearly continu-S100 resin and equilibrated with 25 mM HEPES, 0.3M NaCl, 10% ous density for the protein backbone as well as strong side chain glycerol, 0.1% ␤-octylglucoside, 2 mM ␤-mercaptoethanol (pH 8.0).
density. Approximately 80% of the model could be unambiguously The tNS3 fractions, identified by SDS-PAGE, were pooled and conbuilt into this map (QUANTA 4.1, Molecular Simulations), and a single centrated to 1 mg/ml using a Amicon Centriprep-10, and stored at round of simulated annealing refinement in X-PLOR (Brunger, 1993 ) Ϫ70ЊC. The tNS3 was thawed slowly on ice and the NS4A peptide brought the R-factor to 29% and free R value to 33% (Brunger, (dissolved in the size-exclusion chromatography buffer) was added 1992). The remainder of the model was built and refined in several at a tNS3:NS4A-peptide molar ratio of 1:2. The sample was then steps, by first extending the resolution to 2.5 Å and then adding wellordered water molecules. A final round of positional and individual diluted 2.5-fold with 15 mM MES, 0.5 M NaCl, 20 mM ␤-mercaptoethtemperature factor refinement brought the R-factor to 21.6% (free anol (pH6.5) and concentrated to ‫2ف‬ ml ‫2ف(‬ mg/ml) by ultrafiltration. R value 26.1%) for 26,652 reflections between 6.0 and 2.5Å (F> The sample was then diluted 2-fold with the pH 6.5 buffer and 1F). The eventual model consisted of tNS3 residues 1028-1206 concentrated again to ‫2ف‬ ml. This dilution process was repeated and NS4A residues 21-39 in complex A, and tNS3 residues 1055-until it gave a >40-fold dilution of the original buffer constituents.
1206 and NS4A residues 21-36 for complex B, with 2 zinc atoms The protein sample was then concentrated to 13.0 mg/ml and centriand 130 water molecules. A Ramachandran plot for the final model fuged at ‫000,003ف‬ ϫ g for 20 min at 4ЊC. Concentrations of the contained 91% of the residues in the most favored regions and 0% pure tNS3 and tNS3/4A complex were determined by UV absorption in disallowed or generously allowed regions. The rms deviations spectroscopy, using a molar absorption coefficient (A280) of 17,700 from ideality were 0.007 Å for bond lengths and 1.47Њ for bond M Ϫ1 •cm Ϫ1 . angles.
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